MiNK Therapeutics

About:

MiNK Therapeutics provides Living drugs, Adoptive Cell Therapy, and T Cell Receptors (TCRs).

Website: https://minktherapeutics.com/

Twitter/X: Agentus_CellTX

Top Investors: GKCC

Description:

MiNK Therapeutics is a clinical stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next-generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.